Skip to content

Humanin

Research Use Only
peptideInjection

Protective mitochondrial peptide that shields cells from oxidative stress, supports brain cell survival, and protects the heart.

Key Facts

  • Classification
    Peptide — Protective mitochondrial peptide that shields cells from oxidative damage.
  • Primary Benefits
    Longevity (8/10) · Brain & Cognition (5/10) · Inflammation (5/10)
  • Administration
    Injection
  • Typical Dose
    1-5 mg subq daily. Cycle for 4-8 weeks.
  • Evidence Strength
    Emerging — 20 peer-reviewed studies referenced · Community sentiment 9/10
  • Stacks Well With
    MOTS-c, SS-31
  • Legal Status
    Research Use Only · not prescribable in US

Quick Facts

From price
$60
Type
peptide
Administration
Injection
Evidence
emerging
Studies referenced
20
Community sentiment
9/10
Stacks with
2 peptides
Regulatory
Research Use Only

Top benefits

Longevity
8/10
🧠 Brain & Cognition
5/10
🧊 Inflammation
5/10
1

Week 1–2

Subtle cellular-level effects — cytoprotection and mitochondrial support beginning. No dramatic subjective changes expected.

2

Week 3–6

Mild improvements in energy and cognitive clarity. Enhanced mitochondrial function. Neuroprotective effects building.

3

Week 8+

Cumulative anti-aging and cytoprotective benefits. Improved metabolic markers. Enhanced cellular resilience to stress.

Common Side Effects

Injection site reactionsMild fatigueLimited human data on side effects
Tolerance: None expected — endogenous mitochondrial peptide
Cycling: 8-12 weeks on, 4 weeks off. Very limited clinical data — conservative cycling recommended.

Dosing

1-5 mg subq daily. Cycle for 4-8 weeks.

Reconstitution, storage, injection sites & timing

Benefit Profile

Longevity
8/10
🧠 Brain & Cognition
5/10
🧊 Inflammation
5/10